Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
/PRNewswire/ -- Abbott (NYSE: ABT) today announced its developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor....
Source: prnewswire.com